State Street’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,414,306
Closed -$162M 4291
2025
Q3
$162M Buy
3,414,306
+668,742
+24% +$32.4M 0.01% 1065
2025
Q2
$147M Buy
2,745,564
+250,821
+10% +$11.4M 0.01% 1094
2025
Q1
$101M Buy
2,494,743
+158,799
+7% +$6.73M ﹤0.01% 1262
2024
Q4
$65M Sell
2,335,944
-167,002
-7% -$5.06M ﹤0.01% 1588
2024
Q3
$71.8M Sell
2,502,946
-186,480
-7% -$4.86M ﹤0.01% 1515
2024
Q2
$63.1M Sell
2,689,426
-1,108,304
-29% -$23.7M ﹤0.01% 1541
2024
Q1
$95.9M Sell
3,797,730
-1,325,165
-26% -$31.8M ﹤0.01% 1333
2023
Q4
$120M Buy
5,122,895
+2,617,047
+104% +$51.6M 0.01% 1173
2023
Q3
$127M Buy
2,505,848
+265,617
+12% +$12.4M 0.01% 1034
2023
Q2
$105M Buy
2,240,231
+9,424
+0.4% +$432K 0.01% 1183
2023
Q1
$85.4M Sell
2,230,807
-270,162
-11% -$12M ﹤0.01% 1292
2022
Q4
$137M Buy
2,500,969
+1,953,347
+357% +$83.7M 0.01% 966
2022
Q3
$18.6M Buy
547,622
+54,770
+11% +$838K ﹤0.01% 2283
2022
Q2
$4.66M Sell
492,852
-746,265
-60% -$7.78M ﹤0.01% 3136
2022
Q1
$17.6M Buy
1,239,117
+206,496
+20% +$3.62M ﹤0.01% 2497
2021
Q4
$21.8M Sell
1,032,621
-121,480
-11% -$2.69M ﹤0.01% 2420
2021
Q3
$25.8M Sell
1,154,101
-75,039
-6% -$1.7M ﹤0.01% 2294
2021
Q2
$30.5M Buy
1,229,140
+289,094
+31% +$8.12M ﹤0.01% 2212
2021
Q1
$27.3M Buy
940,046
+112,162
+14% +$3.4M ﹤0.01% 2155
2020
Q4
$21.4M Buy
827,884
+610,271
+280% +$17M ﹤0.01% 2209
2020
Q3
$6.7M Buy
217,613
+30,023
+16% +$1.05M ﹤0.01% 2650
2020
Q2
$4.67M Buy
187,590
+68,806
+58% +$1.57M ﹤0.01% 2793
2020
Q1
$2.52M Buy
118,784
+30,770
+35% +$660K ﹤0.01% 2955
2019
Q4
$1.95M Buy
88,014
+18,560
+27% +$384K ﹤0.01% 3260
2019
Q3
$1.58M Buy
+69,454
New +$1.62M ﹤0.01% 3291

Other funds holding AKRO